CONMED ALTRUS THERMAL TISSUE FUSION SYSTEM
K101534 · Conmedcorp · GEI · Nov 24, 2010 · General, Plastic Surgery
Device Facts
| Record ID | K101534 |
| Device Name | CONMED ALTRUS THERMAL TISSUE FUSION SYSTEM |
| Applicant | Conmedcorp |
| Product Code | GEI · General, Plastic Surgery |
| Decision Date | Nov 24, 2010 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 878.4400 |
| Device Class | Class 2 |
| Attributes | Therapeutic, 3rd-Party Reviewed |
Intended Use
The CONMED ALTRUS® Thermal Tissue Fusion System is indicated for open and laparoscopic techniques in general surgical and gynecological procedures for ligating (sealing) and dividing (cutting) of tissue when hemostasis is desired.
Device Story
System comprises energy source and single-use sterile handpiece. Input: tissue characteristics sensed by handpiece. Operation: closed-loop communication between handpiece and energy source; resistive heating elements in distal handpiece jaws apply focused thermal energy and mechanical pressure to tissue. Output: sealed and divided tissue. Used in OR for open/laparoscopic general and gynecological surgery by surgeons. Energy source uses microprocessors/software to adjust electrical parameters based on real-time tissue feedback. Thermal fusion replaces RF or ultrasonic energy to reduce unintended thermal injury. Provides ligation and dissection capabilities.
Clinical Evidence
Bench testing only. Preclinical laboratory and performance testing conducted to ensure device function and design specification compliance. No clinical data presented.
Technological Characteristics
System uses resistive heating elements for thermal tissue fusion. Components: energy source (LCD, power supply, amplifiers, microprocessors) and single-use handpiece (scissors-type parallel jaw mechanism). Biocompatible materials. Complies with ISO 60601 standards. Closed-loop feedback system adjusts electrical parameters based on tissue response.
Indications for Use
Indicated for patients undergoing open or laparoscopic general surgical and gynecological procedures requiring tissue ligation (sealing) and division (cutting) for hemostasis.
Regulatory Classification
Identification
An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.
Predicate Devices
- Valleylab LigaSure Vessel Sealing System (K981916)
- UltraCision Harmonic Scalpel System (K002906)
Related Devices
- K140459 — ALTRUS THERMAL TISSUE FUSION ENERGY SOURCE, ALTRUS THERMAL TISSUE FUSION HANDPIECE, ALTRUS THERMAL TISSUE FUSION SYSTEM · Conmed Corporation · Jul 11, 2014
- K130596 — CAIMAN SEAL AND CUT TECHNOLOGY · Aesculap, Inc. · Mar 22, 2013
- K140839 — CAIMAN SEAL AND CUT TECHNOLOGY · Aesculap, Inc. · Apr 28, 2014
- K122086 — THERMAL LIGATING SHEARS · Microline Surgical, Inc. · Aug 23, 2012
- K131435 — ENSEAL G2 TISSUE SEALER, STRAIGHT JAW, ENSEAL G2 TISSUE SEALER, CURVED JAW, ENSEAL TRIO TISSUE SEALER, 3 MM CURVED JAW, · Ethicon Endo-Surgery, LLC · Oct 3, 2013
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo for Conmed Electrosurgery. The logo features a stylized "C" shape on the left, followed by the word "CONMED" in bold, sans-serif font. Below "CONMED" is the word "ELECTROSURGERY" in a smaller font. Above the logo is the number "K101534".
Page 1 of 2
NOV 2 4 2010
# Summary of Safety and Effectiveness
| Submitted by: | CONMED Electrosurgery Division<br>14603 East Fremont Avenue<br>Centennial, CO 80112 USA<br>Telephone: 303-269-8224<br>Facsimile: 866-205-9495 |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Shawn Riedel |
| Date Prepared: | March 29, 2010 |
| Proprietary Name: | CONMED Altrus® Thermal Tissue Fusion System |
| Classification Name: | Electrosurgical Cutting and Coagulation Device and accessories<br>21 CFR 878.4400<br>79 GEI |
| Predicate Device: | This product is similar in design, composition, and function to the:<br>Valleylab LigaSure Vessel Sealing System (K981916) cleared August<br>28, 1998, as well as the<br>UltraCision Harmonic Scalpel System (K002906) cleared December<br>15, 2000 |
## Device Description:
The CONMED Altrus Thermal Tissue Fusion system consists of the following:
- CONMED Altrus Thermal Tissue Fusion Energy Source .
- CONMED Altrus Thermal Tissue Fusion Handpiece. .
The CONMED Altrus Thermal Tissue Fusion system employs focused thermal energy and pressure to simultaneously seal and/or seal and divide tissue. By applying direct heat instead of electrical, radio frequency or ultrasonic energy, the ConMed Altrus products can reduce the potential of unintended thermal injury.
The energy source uses an LCD display, a power supply, amplifiers and associated electronic components coupled with several microprocessors and associated software to provide the energy to the accompanying handpiece. The energy source works in harmony with the handpiece in a closed loop communication process. This process allows for the handpiece to provide information to the energy source regarding the tissue and adjust the predetermined electrical parameters in response to the effect on the tissue. As energy is delivered to the heaters in the distal portion of the handpiece, these heaters increase in temperature, by means of simple resistive heating. This thermal effect coupled with mechanical pressure on the vessel provides the means for the fusion of the tissue between the jaws to form the ligation (seal) The cutting effect is accomplished in a similar manner, with a different set of parameters controlled by the software.
{1}------------------------------------------------
Image /page/1/Picture/0 description: The image shows a sequence of characters and numbers: "K101 534.". The characters and numbers are written in a simple, handwritten style. The sequence starts with the letter 'K', followed by the numbers '101', then a space, and then the numbers '534', ending with a period.
Page 2
ସ୍ନ ସ
The CONMED Altrus Thermal Tissue Fusion handpiece is a single use device which is provided sterile. The device uses a scissors to parallel jaw closure mechanism with one flat jaw and one crowned jaw in which the vessels/tissues are grasped and through which pressure and heat are applied. It is a multi-functional device capable of vessel sealing, grasping and dissecting during open general surgical procedures. The two jaw sizes allow for applications in a variety of clinical environments for access in confined areas as well as large open areas.
Energy is delivered to the heaters by a cable which provides power to the handpiece as well as allows for communication to and from the handpiece.
Indications For Use:
The CONMED ALTRUS® Thermal Tissue Fusion System is indicated for open and laparoscopic techniques in general surgical and gynecological procedures for ligating (sealing) and dividing (cutting) of tissue when hemostasis is desired.
### Technological Characteristics:
The technological characteristics of the system are similar to the predicate devices. The clinical applications for the sealing and/or separation of tissue are the same. The CONMED Altrus Thermal Tissue Fusion System is different from the predicates in that it utilizes thermal energy versus Radiofrequency energy (Ligasure) or Ultrasonic energy (UltraCision). Additionally the CONMED Altrus Thermal Tissue Fusion System utilizes thermal energy for cutting versus a mechanical blade found in the predicate (Ligasure).
Both predicate devices are used in general surgical procedures where ligation of vessels is performed.
The CONMED Altrus Thermal Tissue Fusion System complies with all the applicable ISO 60601 Standards as well as being wholly composed of biocompatible materials for all patient or clinician contacting surfaces.
## Performance testing:
Preclinical laboratory and performance testing were performed to ensure the devices functioned as intended and met design specifications. Sufficient data was obtained to demonstrate the CONMED Altrus Thermal Tissue Fusion System was substantially equivalent to or better than the predicate devices.
Summary: The data provide demonstrates the CONMED Altrus Thermal Tissue Fusion system is substantially equivalent to the identified predicate devices in function, construction, intended use, and indications for use.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the circumference. Inside the circle is a stylized image of an eagle or other bird with outstretched wings, depicted in a minimalist, abstract design.
#### Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-O66-0609 Silver Spring, MD 20993-0002
ConMed Corporation % Intertek Testing Services NA, Inc. Ms. Paula Wilkerson, RAC 2307 East Aurora road, Unit B7 Twinsburg, Ohio 44087
NUV 2 4 2010
Re: K101534
Trade/Device Name: CONMED® ALTRUS Thermal Tissue Fusion System Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: II Product Code: GEI Dated: November 11, 2010 Received: November 12, 2010
Dear Ms. Wilkerson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
{3}------------------------------------------------
Page 2 - Ms. Paula Wilkerson, RAC
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of niedical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/A.boutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
Mark A. Milkeren
Mark N. Melkerson Director Division of Surgical. Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Indications for Use
510(k) Number (if known): k101534
י "" 4 NOV 2
Device Name: CONMED ALTRUS® Thermal Tissue Fusion System
Indications for Use:
The CONMED ALTRUS® Thermal Tissue Fusion System is indicated for open and laparoscopic techniques in general surgical and gynecological procedures for ligating (sealing) and dividing (cutting) of tissue when hemostasis is desired.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mark A. Wilkerson
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K101534
Page __ of __